Literature DB >> 1171222

Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal.

H N Bhargava, E L Way.   

Abstract

Levels of brain acetylcholine and choline were measured with a gas chromatograph in Swiss-Webster or ICR mice and Sprague-Dawley rats: a) 30 minutes after various single doses of morphine sulfate s.c.; b) rendered highly tolerant to and dependent on morphine by pellet implantation for 3 days; c) at various times after abrupt withdrawal (pellet removal); or d) during abstinence precipitated by the narcotic antagonist naloxone. The specific activity of brain acetylcholinsterase was determined in treatment d. Brain choline levels generally remained unaffected by the above manipulations. It was found that analgetic doses of morphine did not alter the steady-state levels of brain acetylcholine, but slight increases were observed after high doses and in morphine-tolerant animals. Abrupt withdrawal of morphine in the mouse caused a significant increase in brain acetylcholine levels, which was observed at 6 hours but not at 12 and 24 hours. In rats, abrupt withdrawal had no effect on acetylcholine levels at 6 and 18 hours. Nalonone-precipitated withdrawal significantly lowered the brain acetylcholine in both mice and rats without affecting acetylcholinesterase activity. This lowering was observed in animals that jumped after naloxone, but not in those failed to jump. It is concluded that this decrease in brain acetylcholine may be related to an increased neuronal release.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171222

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

2.  Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

3.  Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.

Authors:  I Ushijima; K Yamada; Y Noda; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Changes in acetylcholinesterase activity and muscarinic receptor bindings in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Lir-Wan Fan; Chiharu Sogawa; Tangeng Ma; Horance H Loh; Ing-Kang Ho
Journal:  Brain Res Mol Brain Res       Date:  2004-07-05

5.  Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.

Authors:  H N Bhargava; G A Matwyshyn
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Lithium in combination with haloperidol or thyrotropin-releasing hormone induces jumping in mice.

Authors:  I Ushijima; K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Glutathione S-transferasesP1 AA (105Ile) allele increases oral cancer risk, interacts strongly with c-Jun Kinase and weakly detoxifies areca-nut metabolites.

Authors:  Pallavi Yadav; Atanu Banerjee; Nabamita Boruah; Chongtham Sovachandra Singh; Puja Chatterjee; Souvik Mukherjee; Hughbert Dakhar; Henry B Nongrum; Atanu Bhattacharjee; Anupam Chatterjee
Journal:  Sci Rep       Date:  2020-04-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.